Jyong Biotech Ltd. (MENS)
NASDAQ: MENS · Real-Time Price · USD
2.350
+0.190 (8.80%)
At close: Mar 9, 2026, 4:00 PM EDT
2.300
-0.050 (-2.13%)
After-hours: Mar 9, 2026, 4:45 PM EDT
Jyong Biotech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 1.13 | 1.13 | 1.73 | 1.54 | 0.85 | 0.93 |
| Research & Development | 0.8 | 0.93 | 1.07 | 1.29 | 1.56 | 1.52 |
| Operating Expenses | 1.92 | 2.06 | 2.8 | 2.83 | 2.4 | 2.45 |
| Operating Income | -1.92 | -2.06 | -2.8 | -2.83 | -2.4 | -2.45 |
| Interest Expense | -1 | -1.04 | -0.76 | -0.77 | -0.84 | -0.85 |
| Interest & Investment Income | 0.03 | 0.01 | 0.06 | 0.01 | 0.01 | 0.01 |
| Other Non Operating Income (Expenses) | -0.05 | 0.07 | -0.9 | -3.04 | -0.97 | 1.36 |
| Pretax Income | -2.95 | -3.02 | -4.4 | -6.63 | -4.2 | -1.92 |
| Net Income | -2.95 | -3.02 | -4.4 | -6.63 | -4.2 | -1.92 |
| Net Income to Common | -2.95 | -3.02 | -4.4 | -6.63 | -4.2 | -1.92 |
| Shares Outstanding (Basic) | 72 | 72 | 72 | 72 | 72 | 72 |
| Shares Outstanding (Diluted) | 72 | 72 | 72 | 72 | 72 | 72 |
| EPS (Basic) | -0.04 | -0.04 | -0.06 | -0.09 | -0.06 | -0.03 |
| EPS (Diluted) | -0.04 | -0.04 | -0.06 | -0.09 | -0.06 | -0.03 |
| Free Cash Flow | - | -3.62 | -2.6 | -3.22 | -2.12 | -1.18 |
| Free Cash Flow Per Share | - | -0.05 | -0.04 | -0.04 | -0.03 | -0.02 |
| EBITDA | -1.8 | -1.94 | -2.67 | -2.71 | -2.28 | -2.34 |
| D&A For EBITDA | 0.12 | 0.12 | 0.13 | 0.12 | 0.12 | 0.11 |
| EBIT | -1.92 | -2.06 | -2.8 | -2.83 | -2.4 | -2.45 |
Source: S&P Capital IQ. Standard template.
Financial Sources.